Virax Biolabs Group (VRAX) Cash Flow: Operating & Free Cash Flow

Virax Biolabs Group Cash Flow Statement Analysis

Values in millions USD

Income Statement Balance Sheet Cash Flow Ratios

Scale:

Scroll to see more

Cash flow statement showing operating, investing, and financing activities for Virax Biolabs Group Limited (VRAX) - Annual data in millions USD
Breakdown	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022	FY 2022	FY 2021	FY 2020
Period ending	Mar 2026	Mar 2025	Mar 2024	Mar 2023	Sep 2022	Mar 2022	Mar 2021	Mar 2020
Operating Activities
Net Income	-5.03	-6.07	-6.74	-5.46	-1.71	-1.75	-0.65	-0.74
Depreciation & Amortization	0.36	0.27	0.10	0.00	0.00	-	0.00	0.00
Stock Based Compensation	0.13	0.37	1.01	1.73	0.29	0.29	0.00	0.00
Change in Working Capital	0.26	0.63	-1.12	-0.22	0.64	0.64	0.06	-0.10
Change in Accounts Receivable	0.00	0.22	-0.22	0.00	0.00	0.00	0.00	0.00
Change in Inventory	0.09	-0.03	-0.06	0.02	0.00	0.00	-0.02	0.00
Change in Accounts Payable	-0.01	0.47	-0.57	0.03	0.64	0.64	0.08	-0.10
Change in Other Working Capital	0.18	0.19	-0.27	-0.24	0.00	0.30	0.00	0.00
Other Operating Activities	-0.34	0.25	0.50	-0.26	-0.03	0.30	0.00	0.09
Net Cash from Operating Activities	-4.62	-4.56	-6.25	-4.18	-0.81	-0.81	-0.59	-0.74
Investing Activities
Capital Expenditures	-0.26	-0.60	-1.16	-0.18	0.00	-	0.00	0.00
Other Investing Activities	0.00	0.00	-0.21	-0.18	0.00	-	0.00	0.00
Net Cash from Investing Activities	-0.26	-0.60	-1.16	-0.18	0.00	-	0.00	0.00
Financing Activities
Debt Repayment	-0.11	-0.11	-0.21	0.15	0.10	-	0.00	0.00
Common Stock Issued	7.20	5.91	0.00	13.65	0.52	0.52	0.40	0.00
Other Financing Activities	-0.11	-0.11	1.85	-0.11	0.19	0.19	0.59	0.70
Net Cash from Financing Activities	7.09	5.81	1.65	13.69	0.81	0.81	0.59	0.70
Summary
Net Change in Cash	2.21	0.64	-5.76	9.33	0.00	0.00	0.00	-0.04
Cash at Beginning of Period	4.23	3.59	9.35	0.02	0.02	0.02	0.02	0.06
Cash at End of Period	6.44	4.23	3.59	9.35	0.02	0.02	0.02	0.02
Free Cash Flow	-4.88	-5.17	-7.41	-4.36	-0.81	-0.81	-0.59	-0.74

Source: Company financial statements from annual and quarterly filings. Data as of Mar 31, 2026. Data sources and methodology

Frequently Asked Questions About Virax Biolabs Group Cash Flow

What is Virax Biolabs Group's free cash flow?

Virax Biolabs Group had negative free cash flow of $4.88M in fiscal 2026 (fiscal year ended Mar 31, 2026), operating cash flow of −$4.62M minus $255.83K of capital expenditures.

How much does Virax Biolabs Group spend on capital expenditures?

Virax Biolabs Group spent $255.83K on capital expenditures in fiscal 2026, compared with $603.89K a year earlier.

Does Virax Biolabs Group pay dividends or buy back shares?

Virax Biolabs Group's cash flow statement for fiscal 2026 shows no dividend payments or share repurchases.

What is free cash flow?

Free cash flow is operating cash flow minus capital expenditures. It is the cash a company has left for dividends, buybacks, debt repayment or acquisitions after funding its operations and investment. Full definition